Here are some of the latest advances in medical science ¹ ²:
– *Gene Editing*: The U.S. Food and Drug Administration (FDA) approved the world’s first CRISPR/Cas9 gene-editing therapy, Casgevy, in December 2023, to target sickle cell disease.
– *Alzheimer’s Treatment*: The FDA approved an Alzheimer’s drug called lecanemab (brand name Leqembi) in July 2023.
– *Muscular Dystrophy Treatment*: In June 2023, the FDA approved the first gene therapy for children with Duchenne muscular dystrophy.
– *RSV Vaccine*: The FDA approved the first RSV vaccine, called Arexvy, in May 2023, for adults age 60 and older.
– *HIV-1 Strains*: Researchers have developed a new antibody therapy that can neutralize a wide variety of HIV-1 strains.
– *Neuroprosthetic Interface*: Researchers have restored a natural walking gait in people with amputations below the knee with a new surgical intervention and neuroprosthetic interface.
– *Universal Influenza Vaccine*: Researchers are developing a universal influenza vaccine that confers lifetime immunity against an evolving virus.
– *Respiratory Syncytial Virus*: Scientists have discovered how the dangerous Respiratory Syncytial Virus (RSV) defuses our immune response and have pinpointed an exciting new target for drug development.
GIPHY App Key not set. Please check settings